Korelasi antara Kadar Kalsidiol (25-Oh) dan Rasio Netrofil-Limfosit dengan Keganasan Nodul Tiroid
DOI:
https://doi.org/10.35790/ecl.v12i2.48492Abstract
Abstract: Thyroid malignancy has shown the highest annual incidence rate. Vitamin D deficiency (serum 25-hydroxyvitamin D levels) is one of the risk factors for thyroid malignancy. The neutrophil-lymphocyte ratio (NLR) reflects the balance between pro-tumor inflammatory response and anti-tumor immune response. This study aimed to investigate the relationship between serum 25-hydroxyvitamin D levels, NLR, and thyroid nodule malignancy. This was an observational and analytical study with cross-sectional design. Samples were patients with thyroid nodules admitted to Prof. Dr. R. D. Kandou Hospital, Manado, form August 2022 to March 2023. The results obtained a total of 46 patients with thyroid malignancy that met the inclusion criteria. The patient characteristics were predominantly female (82.6%), with a mean age of 50.2 ± 14.74 years, normal thyroid hormone status (82.6%), mean serum 25-hydroxyvitamin D levels of 32.25 ng/mL, mean NLR of 5, and papillary carcinoma as the most common malignancy (43.48%). Spearman's correlation analysis revealed a significant association between thyroid malignancy and serum 25-hydroxyvitamin D levels (r =-0.501, p=0) as well as NLR (r 0.376, p=0.01). In conclusion, serum 25-hydroxyvitamin D levels and NLR can be used as indicators for predicting thyroid nodule malignancy.
Keywords: thyroid malignancy; 25-hydroxyvitamin D; neutrophil-lymphocyte ratio
Abstrak: Keganasan tiroid mengalami peningkatan angka kejadian tertinggi pertahun. Kekurangan vitamin D (kadar kalsidiol) merupakan salah satu faktor risiko terjadinya keganasan tiroid. Rasio netrofil limfosit (RNL) mencerminkan keseimbangan antara respon inflamasi protumor dan respon imun antitumor. Penelitian ini bertujuan untuk mengevaluasi hubungan antara kadar 25-hydroxyvitamin D serum dan RNL dengan keganasan nodul tiroid. Jenis penelitian ialah analitik observasional dengan desain potong lintang. Sampel penelitian ialah pasein dengan nodul tiroid yang dirawat di RSUP Prof. Dr. R. D. Kandou Hospital, Manado, sejak Agustus 2022 s/d Maret 2023. Hasil penelitian mendapatkan 46 pasien dengan keganasan tiroid yang memenuhi kriteria. Karakteristik sampel tebanyak ialah jenis kelamin perempuan (82,6%), rerata usia (50,2±14,74 tahun), status hormon tiroid normal (82,6%), rerata kadar 25-hydroxyvitamin D 32,25 ng/mL, rerata RNL 5, dan jenis keganasan karsinoma papiler (43,48%). Uji analisis Spearman menunjukkan keganasan tiroid secara bermakna berhubungan dengan kadar kalsidiol (r=-0,501, p=0), dan RNL (r=0,376, p=0,01). Simpulan penelitian ini ialah kadar 25-hydroxyvitamin D serum dan RNL dapat digunakan sebagai indikator untuk memrediksi keganasan nodul tiroid.
Kata Kunci: keganasan tiroid; 25-hydroxyvitamin D; rasio netrofil-limfosit
References
Global Burden of Disease Cancer Collaboration, Fitzmaureice C, Abate D, Abbasi N, Abbastabar H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with dis ability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749-68. Doi: 10.1001/jamaoncol. 2019.2996
World Health Organization. Number of new cases in 2020, both sexes, all ages. The Global Cancer Observatory. Cureus. 2020;11(2):e4127.
World Health Organization. Indonesia cancer. The Global Cancer Observatory. 2018. p1-2.
Haugen BR. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed? Cancer. 2017;123(3):372-81. Doi: 10.1002/cncr.30360
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov NJ, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133. Doi: 10.1089/thy.2015.0020.
Shah J. Thyroid carcinoma: epidemiology, histology, and diagnosis. Clin Adv Hematol Oncol. 2015;13(4 Suppl 4):3-6. Available from: https:// pubmed.ncbi.nlm.nih.gov/26430868/
Stepien T, Krupinski R, Sopinski J, Kuzdak K, Komorowski J, et al. Decreased 1-25 dihydroxy vitamin D3 concentration in peripheral blood serum of patients with thyroid cancer. Arch Med Res. 2010;41(3):190-4. Doi: 10.1016/j.arcmed.2010.04.004
Campbell M, Trump DL. Vitamin D receptor signaling and cancer. Endocrinol Metab Clin North Am. 2017;46(4):1009-38. Doi: 10.1016/j.ecl.2017.07.007
Roskies M, Dolev Y, Caglar D, Hier MP, Mlynarek A, Majdan A, et al. Vitamin D deficiency as a potentially modifiable risk factor for thyroid cancer. J Otolaryngol Head Neck Surg. 2012;41(3):160-3. Available from: https:// pubmed.ncbi.nlm.nih.gov/22762696/
Kim JR, Kim BH, Kim SM, Oh MY, Kim WJ, Jeon YK, et al. Low sefolikrum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer. Thyroid. 2014;24(11):1618-24. Doi: 10.1089/thy.2014.0090
Suzuki S, Takenoshita S, Furukawa H, Tsuchiya A. Antineoplastic activity of l,25(OH)2D3 and its analogue 22-oxacalcitriol against human anaplastic thyroid carcinoma cell lines in vitro. Int J Mol Med. 1999;4(6):611-4. Doi: 10.3892/ijmm.4.6.611
Deeb KK, Trump TL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7(9):684-700. Doi: 10.1038/nrc2196
Dutta D, Sharma1 M, Aggarwal S, Mohindra R, Bhattacharya S, Kalra S. Vitamin D, thyroid autoimmunity and cancer: an interplay of different factors. Indian J Endocrinol Metab. 2019;23(5):507-13. Doi: 10.4103/ijem.IJEM_526_19
Zhao J, Wang H, Zhang Z, Zhou X, Yao J, Zhang R, et al. Vitamin D deficiency as a risk factor for thyroid cancer: a meta-analysis of case-control studies. The end-to-end journal. Nutrition. 2019:57:5-11. Doi: 10.1016/j.nut.2018.04.015
Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, et al. The role of vitamin D in cancer prevention. Am J Public Health. 2006;96(2):252-61. Doi: 10.2105/AJPH.2004.045260
Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14(5):342-57. Doi: 10.1038/nrc3691
Tabatabaeizadeh SA, Avan A, Bahrami A, Khodashenas E, Esmaeili H, Ferns GA, et al. High-dose supplementation of vitamin D affects measures of systemic inflammation: reductions in high-sensitivity C-reactive protein level and neutrophil to lymphocyte ratio (NLR) distribution. J Cell Biochem. 2017;118(12):4317-22. Doi: 10.1002/jcb.26084
Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res. 2014 May 29:7:69-87. doi: 10.2147/JIR.S63898
Akbas EM, Gungor A, Ozcicek A, Akbas N, Askin S, Polat M. Vitamin D and inflammation: evaluation with neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio. Arch Med Sci. 2016;12(4):721-7. Doi: 10.5114/aoms.2015.50625
Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A, Jailon S. Tumor associated macrophages and neutrophils in cancer. Immunobiology. 2013;218(11):1402-10. Doi: 10.1016/j.imbio.2013.06.003
Ma SJ, Yu H, Khan M, Gill J, Santhosh S, Chatterjee U, et al. Evaluation of optimal threshold of neutrophil-lymphocyte ratio and its association with survival outcomes among patient with head and neck cancer. JAMA Network Open. 2022;5(4):e227567. Doi: 10.1001/jamanetworkopen.2022.7567
Yaylacı S, Tosun O, Sahin O, Genc AB, Aydin E, Demiral G, et al. Lack of variation in inflammatory hematological parameters between benign nodular goiter and papillary thyroid cancer. Asian Pac J Cancer Prev. 2016;17(4):2321-3. Doi: 10.7314/apjcp.2016.17.4.2321
Liu W, Zhang L, Xu H-J, Li Y, Hu C-M, Yang JY, et al. The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis. Int J Mol Sci. 2018;19(9):2736. doi: 10.3390/ijms19092736
Bartlett EK, Flynn JR, Panageas KS, Ferraro RA, Sta Cruz JM, Postow MA, et al. High neutrophil to lymphocyte ratio (NLR) is associated with treatment failure and death in melanoma patients treated with PD-1 inhibitor monotherapy. Cancer. 2020;126(1):76-85. Doi: 10.1002/cncr.32506
Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc. 2010;85(8):752-7. Doi: 10.4065/mcp.2010.0138
Hu MJ, Zhang Q, Liang L, Wang S-Y, Zheng X-C, Zhou M-M, et al. Association between vitamin D deficiency and risk of thyroid cancer: a case-control study and a meta-analysis. J Endocrinol Invest. 2018;41(10):1199-210. Doi: 10.1007/s40618-018-0853-9
Zabel M, Flig K, Gębarowska E, Zasada JS. The effect of calcitriol and its analogues on proliferation and hormone expression in cultured cells of thyroid medullary carcinomas. Folia Morphol. 2003;62(4):463-5. Available from: https://europepmc.org/article/MED/14655142
Balla B, Tobias B, Kosa JP, Podani J, Horvath P, Nagy Z, et al. Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer. J Endocrinol Invest. 2015 Mar;38(3):313-21. Doi: 10.1007/s40618-014-0165-7
Laney N, Meza J, Lyden E, Erickson J, Treude K, Goldner W. The prevalence of vitamin D deficiency is similar between thyroid nodule and thyroid cancer patients. International Journal of Endocrinology. 2009:2010:805716. Available from: https://doi.org/10.1155/2010/805716
Jonklaas J, Danielsen M, Wang H. A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer. Thyroid. 2013;23(9):1079-86. Doi: 10.1089/thy.2012.0548
Ahn HY, Chung YJ, Park K-Y, Cho BY. Serum 25-hydroxyvitamin D level does not affect the aggressiveness and prognosis of papillary thyroid cancer. Thyroid. 2016;26(3):429-33. Doi: 10.1089/thy.2015.0516
Warakomski J, Romuk E, Jarząb B, Krajewska J, Siemińska L. Concentrations of selected adipokines, interleukin-6, and vitamin D in patients with papillary thyroid carcinoma in respect to thyroid cancer stages. Int J Endocrinol. 2018:2018:4921803. Doi: 10.1155/2018/4921803
Kuang J, Jin Z, Chen L, Zhao Q, Huang H, Liu Z, et al. Serum 25-hydroxyvitamin D level is unreliable as a risk factor and prognostic marker in papillary thyroid cancer. Ann Transl Med. 2022;10(4):193. Doi: 10.21037/atm-22-10.
Feng J, Wang Y,Shan G, Gao L.Clinical and prognostic value of neutrophil-lymphocyte ratio for patients with thyroid cancer. Medicine. Cina. 2020.p1-8.
Cheong TY, Hong DSJung K-W, So YK. The diagnostic predictive value of neutrophil-to-lymphocyte ratio in thyroid cancer adjusted for tumor size. Plos One. 2021;16(5):e0251446. Doi: 10.1371/ journal.pone.0251446
Kocer D, Karakukcu C, Karaman H, Gokay F, Bayram F. May the neutrophil/lymphocyte ratio be a predictor in the differentiation of different thyroid disorders? Asian Pac J Cancer Prev. 2015;16(9): 3875-9. Doi: 7314/apjcp.2015.16.9.3875
Riguetto CM, Barreto IS, Maia FFR, da Assumpção LVM, Zantut-Wittmann DEZ. Usefulness of pre-thyroidectomy neutrophil–lymphocyte, platelet–lymphocyte, and monocyte–lymphocyte ratios for discriminating lymph node and distant metastases in differentiated thyroid cancer. Clinics (Sao Paulo). 2021:76:e3022. Doi: 10.6061/clinics/2021/e3022
Park JY, Park J, Shin J-H, Oh J-L, Jung H-A, Chung M-K, et al. Prognostic value of the neutrophil-to-lymphocyte ratio before and after radiotherapy for anaplastic thyroid carcinoma. Cancers (Basel). 2021;13(8):1913. Doi: 10.3390/cancers13081913
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Bryan D. Bogar, Nico Lumintang, Sherly Tandililing, Windy M. Wariki
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
COPYRIGHT
Authors who publish with this journal agree to the following terms:
Authors hold their copyright and grant this journal the privilege of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that permits others to impart the work with an acknowledgment of the work's origin and initial publication by this journal.
Authors can enter into separate or additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (for example, post it to an institutional repository or publish it in a book), with an acknowledgment of its underlying publication in this journal.
Authors are permitted and encouraged to post their work online (for example, in institutional repositories or on their website) as it can lead to productive exchanges, as well as earlier and greater citation of the published work (See The Effect of Open Access).
